Tumoral EIF4EBP1 regulates the crosstalk between tumor-associated macrophages and tumor cells in MRTK - PubMed
- ️Mon Jan 01 2024
Tumoral EIF4EBP1 regulates the crosstalk between tumor-associated macrophages and tumor cells in MRTK
Xin Wu et al. Eur J Pharmacol. 2024.
Abstract
Malignant renal rhabdoid tumor (MRTK) is an aggressive and rare malignancy primarily affecting infants and young children. The intricate interactions within the Tumor Microenvironment (TME) are crucial in shaping MRTK's progression. This study elucidates the significance of tumor-associated macrophages(TAMs) within this milieu and their interplay with eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1) in tumor cells, collectively contributing to MRTK's malignant advancement. Through comprehensive analysis of clinical samples and the TARGET database, EIF4EBP1 emerges as a central macrophage-associated gene with robust prognostic implications. Elevated EIF4EBP1 expression correlates with poor prognosis and heightened infiltration of TAMs. Functional validation demonstrates that EIF4EBP1 knockdown in G401 cells significantly attenuates self-proliferation, migration, and invasion. Moreover, EIF4EBP1 regulates macrophage recruitment and M2 polarization through the ERK/P38 MAPK-MIF axis. Notably, M2 macrophages reciprocally foster the malignant behavior of MRTK tumor cells. This study unveils the pivotal role of EIF4EBP1 in propelling MRTK's malignant progression, unraveling a complex regulatory network involving EIF4EBP1 and TAMs. These findings underscore EIF4EBP1 as a promising biomarker and highlight its therapeutic potential in MRTK management.
Keywords: EIF4EBP1; MRTK; Tumor-associated macrophages.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Similar articles
-
BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
Wan P, Chen Z, Zhong W, Jiang H, Huang Z, Peng D, He Q, Chen N. Wan P, et al. Oncol Rep. 2020 Dec;44(6):2475-2486. doi: 10.3892/or.2020.7796. Epub 2020 Oct 8. Oncol Rep. 2020. PMID: 33125143 Free PMC article.
-
Wu X, Mi T, Jin L, Ren C, Wang J, Zhang Z, Liu J, Wang Z, Guo P, He D. Wu X, et al. Cancer Immunol Immunother. 2024 May 7;73(7):122. doi: 10.1007/s00262-024-03702-9. Cancer Immunol Immunother. 2024. PMID: 38714539 Free PMC article.
-
Gui CP, Liao B, Luo CG, Chen YH, Tan L, Tang YM, Li JY, Hou Y, Song HD, Lin HS, Xu QH, Yao GS, Yao HH, Xi-Liu, Luo JH, Cao JZ, Wei JH. Gui CP, et al. Mol Cancer. 2021 Dec 18;20(1):169. doi: 10.1186/s12943-021-01449-w. Mol Cancer. 2021. PMID: 34922539 Free PMC article.
-
LncRNAs act as modulators of macrophages within the tumor microenvironment.
Li K, Xie T, Li Y, Huang X. Li K, et al. Carcinogenesis. 2024 Jun 10;45(6):363-377. doi: 10.1093/carcin/bgae021. Carcinogenesis. 2024. PMID: 38459912 Review.
-
Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.
Qin R, Ren W, Ya G, Wang B, He J, Ren S, Jiang L, Zhao S. Qin R, et al. Clin Exp Med. 2023 Sep;23(5):1359-1373. doi: 10.1007/s10238-022-00888-z. Epub 2022 Sep 29. Clin Exp Med. 2023. PMID: 36173487 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous